Here, a potentially novel mouse model with Treg-specific deficiency of Nox2 in the recipient showed improved allograft outcomes, which were accompanied by reduced cardiomyocyte necrosis, lower myocardial fibrosis, and diminished circulating levels of alloantibodies. Here, CYBB is linked to Myocardial fibrosis.